Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Psoriasis Treatment
... at a CAGR of 6.4% over the analysis period 2023-2030. Interleukin Inhibitors, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$11.8 Billion by the end of ... Read More
-
Antineoplastic Agents
... at a CAGR of 7.1% over the analysis period 2023-2030. Chemotherapeutic Agents Application, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$137.9 Billion by the end ... Read More
-
Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices, Tongue-Retaining Devices), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) & Region - Global Forecast to 2029
... oral appliances market is valued at an estimated 746.6 million in 2029 and is projected to reach USD 471.2 million by 2024, at a CAGR of 9.6% during the forecast period. The increasing number of ... Read More
-
Hair Transplant Services
... by 2030, growing at a CAGR of 14.2% over the analysis period 2023-2030. Platelet-Rich Plasma Therapy, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$7.0 Billion ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Non-Invasive Fat Reduction Technologies
... reach US$6.2 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2023-2030. Cryolipolysis Technology, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach ... Read More
-
Systemic Psoriasis Therapeutics
... by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. TNF Inhibitors, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$18.5 Billion by ... Read More
-
Swine Health
... at a CAGR of 5.8% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Spectator Sports
... at a CAGR of 5.7% over the analysis period 2023-2030. Sports Team and Clubs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$284.6 Billion by the ... Read More
-
Needles
... of 5.0% over the analysis period 2023-2030. Conventional Needles, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$6.6 Billion by the end of the analysis period. ... Read More
-
Transdermal Scopolamine
... at a CAGR of 5.3% over the analysis period 2023-2030. The U.S. Market is Estimated at US$133.3 Million While China is Forecast to Grow at 5.0% CAGR The Transdermal Scopolamine market in the U.S. is ... Read More
-
Coconut Milk
... at a CAGR of 16.4% over the analysis period 2023-2030. Tetra Packs Packaging, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$5.0 Billion by the end ... Read More
-
Healthcare Mobility Solutions
... by 2030, growing at a CAGR of 19.0% over the analysis period 2023-2030. Enterprise Solutions Application, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$147.1 Billion ... Read More
-
Hemoglobinopathies
... of 7.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$676.4 Million by the end of the analysis period. ... Read More
-
Polycaprolactone
... of 8.3% over the analysis period 2023-2030. Coating & Thermoplastic polyurethane (TPU) Application, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$141.2 Million by the end ... Read More
-
Cntx-4975 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
... trans-capsaicin administered via injection directly to the pain site. This innovative treatment harnesses capsaicin’s natural analgesic properties, aiming to provide rapid, long-lasting, and targeted pain relief. CNTX-4975 further works by targeting the TRPV1 receptor, which ... Read More
-
Europe Retinal Surgery Devices Market Report Forecast By Product (Vitrectomy Machines, Vitrectomy Packs, Surgical Instruments, Microscopic Illumination Equipment, Retinal Laser Equipment, Others), Application (Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, Others), End User (Hospitals, Eye Clinics, Others), Countries and Company Analysis (2024-2032)
... Eye Clinics, Others), Countries and Company Analysis (2024-2032) Europe Retinal Surgery Devices Market Analysis The Europe Retinal Surgery Devices Market will reach US$ 1,164.93 million by 2032, up from US$ 633.03 million in 2023, with ... Read More
-
GCC Fragrance & Perfume Market: Market Size, Forecast, Insights, and Competitive Landscape with Cumulative Impact of COVID-19 & Ukraine-Russia War
... 9.3% during 2025-2034. This report on GCC fragrance & perfume market provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the ... Read More
-
Sunitinib Malate
... CAGR of 9.7% over the analysis period 2023-2030. Above 99% Purity Sunitinib Malate, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$109.0 Million by the end ... Read More
-
Sports Management Software
... at a CAGR of 13.2% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$8.2 Billion by the end of ... Read More
-
Rare Hematology
... CAGR of 4.9% over the analysis period 2023-2030. Plasma Derived Factors, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$18.2 Billion by the end of the ... Read More
-
Coagulation Factor Concentrates
... at a CAGR of 7.1% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$8.8 Billion by the ... Read More
-
Hyaluronic Acid
... CAGR of 7.9% over the analysis period 2023-2030. Offline Distribution Channel, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Meal Kit Delivery Services
... 2030, growing at a CAGR of 16.9% over the analysis period 2023-2030. Cook & Eat Meal Kit Delivery Services, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and ... Read More
-
Cellular Concrete
... CAGR of 5.2% over the analysis period 2023-2030. Building Materials Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.5 Billion by the end of the ... Read More
Research Assistance
